VulnerabilityAnalyzed

CVE-2026-21980

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).

MEDIUM 6.5EPSS 0.19%

Does this matter?

Lower severity and a low EPSS score (0.19%). Track it; it rarely justifies an emergency change on its own.

Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVSS 3.1: 6.5 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
EPSS: 0.19% probability · 9th percentile
CISA KEV: Not listed
Affected: oracle/life sciences central coding
Source: secalert_us@oracle.com

References

https://www.oracle.com/security-alerts/cpujan2026.htmlVendor Advisory

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.